Cargando…
Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition
In this cohort study, pricing data from January 2007 to June 2018 from SSR Health were used to determine how list prices, net prices, and discounts for the originator biologics changed with biosimilar competition.
Autores principales: | San-Juan-Rodriguez, Alvaro, Gellad, Walid F., Good, Chester B., Hernandez, Inmaculada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938676/ https://www.ncbi.nlm.nih.gov/pubmed/31834391 http://dx.doi.org/10.1001/jamanetworkopen.2019.17379 |
Ejemplares similares
-
Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2021) -
Estimated Changes in Insulin Prices and Discounts After Entry of New Insulin Products, 2012-2019
por: Dickson, Sean, et al.
Publicado: (2023) -
Cross-sectional Study on the Impact of Discount Pricing and Price Competition on Community Pharmacy Practice
por: Mathews, Allan, et al.
Publicado: (2020) -
Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
por: Dickson, Sean R., et al.
Publicado: (2021) -
Impact of discounts on medicine prices
por: Schneider, Peter, et al.
Publicado: (2015)